🇺🇸 FDA
Patent

US 10525090

Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

granted A61KA61K35/763A61K9/0014

Quick answer

US patent 10525090 (Compositions and methods for the treatment of autosomal recessive congenital ichthyosis) held by Krystal Biotech, Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Krystal Biotech, Inc.
Grant date
Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K35/763, A61K9/0014, A61P, A61P17/00